{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:08:11Z","timestamp":1788973691996,"version":"build-2803163510"},"reference-count":255,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019224","name":"King Faisal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020912","name":"King Faisal University","doi-asserted-by":"publisher","award":["KFU263944"],"award-info":[{"award-number":["KFU263944"]}],"id":[{"id":"10.13039\/501100020912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.slasd.2026.100331","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:04:56Z","timestamp":1786637096000},"page":"100331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modern therapies: Nanotechnology promises new approaches for rare breast cancer brain metastases"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-3559","authenticated-orcid":false,"given":"Ghazala","family":"Muteeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Y.","family":"El-sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"AboHoussien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan H.","family":"Abuelnile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joud Ibrahim A","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheeba","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Aatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa S.R.","family":"Khafaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.slasd.2026.100331_bib0001","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11060-016-2075-3","article-title":"Brain metastasis in breast cancer: a comprehensive literature review","volume":"127","author":"Rostami","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.18632\/oncotarget.27453","article-title":"Risk factors for breast cancer brain metastases: a systematic review","volume":"11","author":"Koniali","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.slasd.2026.100331_bib0003","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/ijms12053303","article-title":"Nanomedicine: application areas and development prospects","volume":"12","author":"Boulaiz","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.slasd.2026.100331_bib0004","article-title":"Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0005","article-title":"Recent advances in green synthesized nanoparticles: from production to application","volume":"24","author":"Hosseingholian","year":"2023","journal-title":"Mater Today Sustain"},{"key":"10.1016\/j.slasd.2026.100331_bib0006","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1515\/gps-2022-0081","article-title":"Limitations of nanomaterials insights in green chemistry sustainable route: review on novel applications","volume":"11","author":"Pal","year":"2022","journal-title":"Green Process Synth"},{"key":"10.1016\/j.slasd.2026.100331_bib0007","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ijc.34542","article-title":"Nanoparticle drug delivery to target breast cancer brain metastasis: current and future trends","volume":"153","author":"Kannan","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0008","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-023-01440-5","article-title":"Applications of synthetic biology in medical and pharmaceutical fields","volume":"8","author":"Yan","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.slasd.2026.100331_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218690","article-title":"Immunotherapy resistance in triple-negative breast cancer: mechanisms and emerging therapeutic strategies","volume":"658","author":"Zhao","year":"2026","journal-title":"Cancer Lett"},{"key":"10.1016\/j.slasd.2026.100331_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119707","article-title":"Innovations in peptide-based targeted therapies for breast cancer: from conjugates to precision delivery","volume":"201","author":"Ghazani","year":"2026","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.slasd.2026.100331_bib0011","article-title":"Precision breast oncology: molecular insights and transformative clinical strategies","volume":"47","author":"Chauhan","year":"2026","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.slasd.2026.100331_bib0012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CACancer J Clin"},{"key":"10.1016\/j.slasd.2026.100331_bib0013","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1158\/1055-9965.EPI-16-0889","article-title":"Estimation of the number of women living with metastatic breast cancer in the United States. Cancer epidemiology","volume":"26","author":"Mariotto","year":"2017","journal-title":"Biomark Prev"},{"key":"10.1016\/j.slasd.2026.100331_bib0014","unstructured":"American Cancer Society (2022) Breast Cancer Facts & Figures 2022\u20132024, Atlanta."},{"key":"10.1016\/j.slasd.2026.100331_bib0015","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cncr.20797","article-title":"Breast carcinoma in men","volume":"103","author":"Anderson","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-018-4921-9","article-title":"Male breast cancer: a disease distinct from female breast cancer","volume":"173","author":"Gucalp","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.slasd.2026.100331_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt465","article-title":"Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results","volume":"106","author":"Brinton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.slasd.2026.100331_bib0018","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/annonc\/mdt025","article-title":"Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship","volume":"24","author":"Ruddy","year":"2013","journal-title":"Ann Oncol 2F Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0019","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.slasd.2026.100331_bib0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10549-017-4383-5","article-title":"Risk of mortality of node-negative, ER\/PR\/HER2 breast cancer subtypes in T1, T2, and T3 tumors","volume":"165","author":"Parise","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.slasd.2026.100331_bib0021","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1158\/1055-9965.EPI-17-0627","article-title":"Differences in breast cancer survival by molecular subtypes in the United States","volume":"27","author":"Howlader","year":"2018","journal-title":"Cancer Epidemiol Biomark Prev 2F: Publ Am Assoc Cancer Res cosponsored Am Soc Prev Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0022","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-005-9101-z","article-title":"The natural history of ductal carcinoma in situ of the breast: a review","volume":"97","author":"Erbas","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.slasd.2026.100331_bib0023","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1200\/OP.21.00020","article-title":"Management of early-stage Human epidermal growth factor receptor 2-positive breast cancer","volume":"17","author":"Pernas","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.slasd.2026.100331_bib0024","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2017.19130","article-title":"Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012","volume":"319","author":"Plevritis","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.slasd.2026.100331_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.2012-0397","article-title":"Molecular characterization of basal-like and non-basal-like triple-negative breast cancer","volume":"18","author":"Prat","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.slasd.2026.100331_bib0026","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0027","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0028","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/cncr.21778","article-title":"Metastatic patterns in adenocarcinoma","volume":"106","author":"Hess","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0029","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00007611-198809000-00011","article-title":"Breast cancer: metastatic patterns and their prognosis","volume":"81","author":"Patanaphan","year":"1988","journal-title":"South Med J"},{"key":"10.1016\/j.slasd.2026.100331_bib0030","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.1984.2.12.1352","article-title":"Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies","volume":"2","author":"Feld","year":"1984","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0031","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(00)82038-3","article-title":"Lung cancer","volume":"355","author":"Hoffman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.slasd.2026.100331_bib0032","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1073\/pnas.1331931100","article-title":"From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression","volume":"100","author":"Schmidt-Kittler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.slasd.2026.100331_bib0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/91.1.80","article-title":"Dormancy of mammary carcinoma after mastectomy","volume":"91","author":"Karrison","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.slasd.2026.100331_bib0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2008.11.013","article-title":"MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer","volume":"15","author":"Hu","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1535-6108(04)00079-0","article-title":"Metadherin, a cell surface protein in breast tumors that mediates lung metastasis","volume":"5","author":"Brown","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0036","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1083\/jcb.200309112","article-title":"Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis","volume":"164","author":"Wang","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.slasd.2026.100331_bib0037","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nature05760","article-title":"Mediators of vascular remodelling co-opted for sequential steps in lung metastasis","volume":"446","author":"Gupta","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.slasd.2026.100331_bib0038","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","article-title":"TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4","volume":"133","author":"Padua","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0039","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.slasd.2026.100331_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.slasd.2026.100331_bib0041","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0042","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0043","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1172\/JCI22320","article-title":"Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors","volume":"115","author":"Minn","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.slasd.2026.100331_bib0044","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1200\/JCO.2005.03.8802","article-title":"Genes associated with breast cancer metastatic to bone","volume":"24","author":"Smid","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0045","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1097\/00029330-200810020-00006","article-title":"A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-\/lower phenotype metastasis to human bone","volume":"121","author":"Ling","year":"2008","journal-title":"Chin Med J"},{"key":"10.1016\/j.slasd.2026.100331_bib0046","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/scbi.2001.0385","article-title":"Tumour dormancy: findings and hypotheses from clinical research on breast cancer","volume":"11","author":"Demicheli","year":"2001","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.slasd.2026.100331_bib0047","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0048","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00109-015-1357-0","article-title":"The brain metastatic niche","volume":"93","author":"Winkler","year":"2015","journal-title":"J Mol Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/716c0fb2-dbdd-4da5-ad8a-d2b1cdac4ec6","article-title":"Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins","volume":"6","author":"Feng","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.slasd.2026.100331_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbcan.2016.12.001","article-title":"Brain metastasis: unique challenges and open opportunities","volume":"1867","author":"Lowery","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0051","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08021","article-title":"Genes that mediate breast cancer metastasis to the brain","volume":"459","author":"Bos","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.slasd.2026.100331_bib0052","first-page":"1115","article-title":"Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice","volume":"141","author":"Zhang","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.slasd.2026.100331_bib0053","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ncb3094","article-title":"Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis","volume":"17","author":"Fong","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.slasd.2026.100331_bib0054","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/PPO.0000000000000126","article-title":"The biology of brain metastasis: challenges for therapy","volume":"21","author":"Fidler","year":"2015","journal-title":"Cancer J"},{"key":"10.1016\/j.slasd.2026.100331_bib0055","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.2353\/ajpath.2010.090838","article-title":"Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis","volume":"176","author":"Lorger","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.slasd.2026.100331_bib0056","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1593\/neo.11112","article-title":"Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy","volume":"13","author":"Kim","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.slasd.2026.100331_bib0057","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418785502","article-title":"New developments in brain metastases","volume":"11","author":"Berghoff","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.slasd.2026.100331_bib0058","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ijrobp.2011.02.027","article-title":"Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases","volume":"82","author":"Sperduto","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0059","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/2152-7806.111298","article-title":"Imaging of brain metastases","volume":"4","author":"Fink","year":"2013","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.slasd.2026.100331_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2016.00030","article-title":"The current and future treatment of brain metastases","volume":"3","author":"Hardesty","year":"2016","journal-title":"Front Surg"},{"key":"10.1016\/j.slasd.2026.100331_bib0061","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41416-019-0619-y","article-title":"Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort","volume":"121","author":"Darlix","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0062","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11060-004-8093-6","article-title":"Brain metastases: epidemiology and pathophysiology","volume":"75","author":"Gavrilovic","year":"2005","journal-title":"J Neurooncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0063","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS metastases in breast cancer","volume":"22","author":"Lin","year":"2004","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0064","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-007-9806-2","article-title":"Brain metastases in breast cancer: prognostic factors and management","volume":"111","author":"Lee","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.slasd.2026.100331_bib0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/02841860500486630","article-title":"Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab","volume":"45","author":"Yau","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0066","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","volume":"23","author":"Kuksis","year":"2021","journal-title":"Neuro-oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0067","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40164-015-0028-8","article-title":"Breast cancer brain metastases: the last frontier","volume":"4","author":"Leone","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0068","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.asjsur.2021.12.037","article-title":"Brain metastasis in de novo breast cancer: an updated population-level study from SEER database","volume":"45","author":"Sun","year":"2022","journal-title":"Asian J Surg"},{"key":"10.1016\/j.slasd.2026.100331_bib0069","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.33243","article-title":"Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson cancer center experience","volume":"148","author":"Gao","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.21037\/atm.2018.04.35","article-title":"Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies","volume":"6","author":"Brosnan","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0071","article-title":"HER2-positive breast cancer brain metastasis: a new and exciting landscape","volume":"5","author":"Zimmer","year":"2022","journal-title":"Cancer Rep"},{"key":"10.1016\/j.slasd.2026.100331_bib0072","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.clbc.2023.07.008","article-title":"Triple negative breast cancer and brain metastases","volume":"23","author":"Bansal","year":"2023","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0073","first-page":"1","article-title":"BRCA1 and BRCA2 mutation variants in early breast cancer confer added prognostic information","volume":"2","author":"Ibrahim","year":"2023","journal-title":"J Cell Mol Immunol"},{"key":"10.1016\/j.slasd.2026.100331_bib0074","article-title":"Prognostic factors of brain metastasis and subsequent survival in breast cancer patients: an 11-year, single-center, retrospective study","volume":"104","author":"Lee","year":"2025","journal-title":"Medicine"},{"key":"10.1016\/j.slasd.2026.100331_bib0075","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1200\/JCO.2014.58.8517","article-title":"Validation and development of a modified breast graded prognostic assessment As a tool for survival in patients with breast cancer and brain metastases","volume":"33","author":"Subbiah","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0076","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.breast.2017.10.006","article-title":"External validation of modified breast graded prognostic assessment for breast cancer patients with brain metastases: a multicentric European experience","volume":"37","author":"Griguolo","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.slasd.2026.100331_bib0077","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0078","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.slasd.2026.100331_bib0079","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.ijrobp.2010.10.077","article-title":"New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases","volume":"82","author":"Niwi\u0144ska","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.slasd.2026.100331_bib0080","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00066-013-0367-5","article-title":"A simple survival score for patients with brain metastases from breast cancer","volume":"189","author":"Rades","year":"2013","journal-title":"Strahlenther Onkol 2F Organ Dtsch Rontgenges"},{"key":"10.1016\/j.slasd.2026.100331_bib0081","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11060-016-2075-3","article-title":"Brain metastasis in breast cancer: a comprehensive literature review","volume":"127","author":"Rostami","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0082","article-title":"A novel sequence variant in COL10A1 causing spondylometaphyseal dysplasia accompanied with coxa valga: a case report","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.slasd.2026.100331_bib0083","article-title":"The regulatory effect of CoL10A1 to the intracranial vascular invasion and cell proliferation in breast cancer via EMT pathway","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2026.100331_bib0084","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1042\/BCJ20210084","article-title":"The roles of epigenetics in cancer progression and metastasis","volume":"478","author":"Chen","year":"2021","journal-title":"Biochem J"},{"key":"10.1016\/j.slasd.2026.100331_bib0085","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78163","article-title":"Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation","volume":"11","author":"Cai","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.slasd.2026.100331_bib0086","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf5473","article-title":"CECR2 drives breast cancer metastasis by promoting NF-\u03bab signaling and macrophage-mediated immune suppression","volume":"14","author":"Zhang","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0087","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3753","article-title":"Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis","volume":"49","author":"McDonald","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.slasd.2026.100331_bib0088","article-title":"An in vivo screen identifies NAT10 as a master regulator of brain metastasis","volume":"11","author":"Chen","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.slasd.2026.100331_bib0089","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13046-024-03200-x","article-title":"NAT10\/ac4C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction","volume":"43","author":"Li","year":"2024","journal-title":"J exp clin cancer res 2F: CR"},{"key":"10.1016\/j.slasd.2026.100331_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41420-021-00474-4","article-title":"Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment?","volume":"7","author":"McNamee","year":"2021","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.slasd.2026.100331_bib0091","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41598-017-02296-w","article-title":"Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer","volume":"7","author":"De Marchi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2026.100331_bib0092","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1245\/s10434-014-4061-3","article-title":"E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer","volume":"22","author":"Chen","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0093","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2398285","article-title":"Analysis of neuroglia and immune cells in the tumor microenvironment of breast cancer brain metastasis","volume":"25","author":"Mo","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.slasd.2026.100331_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115427","article-title":"The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis","volume":"44","author":"Wischnewski","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.slasd.2026.100331_bib0095","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of Human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0096","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0097","article-title":"Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases","volume":"3","author":"Sudmeier","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0098","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s43018-023-00566-3","article-title":"Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation","volume":"4","author":"Wischnewski","year":"2023","journal-title":"Nat cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0099","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0101","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2015.11.009","article-title":"The influence of the pre-metastatic niche on breast cancer metastasis","volume":"380","author":"Ursini-Siegel","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.slasd.2026.100331_bib0102","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ncb3011","article-title":"Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S","volume":"16","author":"Sevenich","year":"2014","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.slasd.2026.100331_bib0103","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1158\/1535-7163.MCT-17-0241","article-title":"The selective Tie2 inhibitor rebastinib blocks recruitment and function of Tie2Hi macrophages in breast cancer and pancreatic neuroendocrine tumors","volume":"16","author":"Harney","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.slasd.2026.100331_bib0104","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.20181454","article-title":"NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing","volume":"216","author":"Prager","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004825","article-title":"ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics","volume":"10","author":"Park","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0106","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ccell.2024.05.006","article-title":"Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2026.110731","article-title":"Comparison between glioblastoma and brain metastases: how epigenetic remodeling can enhance immunotherapy","volume":"286","author":"Celesti","year":"2026","journal-title":"Clin Immunol"},{"key":"10.1016\/j.slasd.2026.100331_bib0108","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jconrel.2023.10.007","article-title":"Engineering CAR-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy","volume":"363","author":"Tao","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.slasd.2026.100331_bib0109","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003050","article-title":"Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors","volume":"9","author":"Jan","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0110","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.slasd.2026.100331_bib0111","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymthe.2024.11.010","article-title":"Proton pump inhibitor attenuates acidic microenvironment to improve the therapeutic effects of MSLN-CAR-T cells on the brain metastasis","volume":"33","author":"Zhai","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.slasd.2026.100331_bib0112","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymthe.2024.11.010","article-title":"Proton pump inhibitor attenuates acidic microenvironment to improve the therapeutic effects of MSLN-CAR-T cells on the brain metastasis","volume":"33","author":"Zhai","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.slasd.2026.100331_bib0113","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2026.100331_bib0114","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res 2F Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0115","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s43018-021-00254-0","article-title":"Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis","volume":"2","author":"Klemm","year":"2021","journal-title":"Nat cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0116","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cell.2020.09.064","article-title":"CNS-native myeloid cells drive immune suppression in the brain metastatic niche through Cxcl10","volume":"183","author":"Guldner","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0117","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-020-0918-0","article-title":"Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis","volume":"26","author":"Brastianos","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0118","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1038\/s41591-024-03261-7","article-title":"Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b\/4 trial","volume":"30","author":"Harbeck","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0119","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s41591-022-01935-8","article-title":"Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial","volume":"28","author":"Bartsch","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.08.001","article-title":"The DEBBRAH trial: trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis","volume":"6","author":"Vaz Batista","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0121","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.annonc.2020.06.020","article-title":"Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial\u2606","volume":"31","author":"Montemurro","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0122","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s40364-025-00854-3","article-title":"Decoding the mechanisms underlying breast cancer brain metastasis: paving the way for precision therapeutics","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0123","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.963004","article-title":"Liposomes as multifunctional nano-carriers for medicinal natural products","volume":"10","author":"Cheng","year":"2022","journal-title":"Front Chem"},{"key":"10.1016\/j.slasd.2026.100331_bib0124","doi-asserted-by":"crossref","first-page":"344","DOI":"10.20517\/evcna.2024.19","article-title":"Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design","volume":"5","author":"Hagedorn","year":"2024","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"10.1016\/j.slasd.2026.100331_bib0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2022.08.001","article-title":"Stimuli-responsive liposomal nanoformulations in cancer therapy: pre-clinical & clinical approaches","volume":"351","author":"Ashrafizadeh","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.slasd.2026.100331_bib0126","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acs.bioconjchem.6b00736","article-title":"Enzyme-responsive liposomes for the delivery of anticancer drugs","volume":"28","author":"Fouladi","year":"2017","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.slasd.2026.100331_bib0127","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s13346-025-01930-9","article-title":"Thermoresponsive nanoparticles for targeted and controlled delivery of doxorubicin in triple negative breast cancer: a 2D and 3D in vitro evaluation","volume":"16","author":"Ribeiro","year":"2026","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0128","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/molecules29030636","article-title":"Light-responsive and dual-targeting liposomes: from mechanisms to targeting strategies","volume":"29","author":"Agiba","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.slasd.2026.100331_bib0129","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2022.1067144","article-title":"Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: current progress and challenges","volume":"4","author":"Das","year":"2023","journal-title":"Front Med Technol"},{"key":"10.1016\/j.slasd.2026.100331_bib0130","first-page":"20","article-title":"Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy","volume":"10","author":"Ma","year":"2023","journal-title":"Mil Med Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0131","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.slasd.2026.100331_bib0132","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.slasd.2026.100331_bib0133","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0134","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0136","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1227\/01.neu.0000318159.21731.cf","article-title":"Glioma extent of resection and its impact on patient outcome","volume":"62","author":"Sanai","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.slasd.2026.100331_bib0137","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0138","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0139","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.slasd.2026.100331_bib0140","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","article-title":"Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis","volume":"2","author":"Brown","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0141","doi-asserted-by":"crossref","first-page":"166","DOI":"10.14791\/btrt.2023.0012","article-title":"Supramaximal resection for glioblastoma: redefining the extent of resection criteria and its impact on survival","volume":"11","author":"Roh","year":"2023","journal-title":"Brain Tumor Res Treat"},{"key":"10.1016\/j.slasd.2026.100331_bib0142","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0143","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.slasd.2026.100331_bib0144","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0145","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2013.49.6968","article-title":"Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial","volume":"31","author":"Gilbert","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0146","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/onco4040025","article-title":"Impact of extent of resection on overall survival in glioblastomas: an Umbrella review of meta-analyses","volume":"4","author":"Jagtiani","year":"2024","journal-title":"Onco"},{"key":"10.1016\/j.slasd.2026.100331_bib0147","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12672-025-02567-3","article-title":"Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance","volume":"16","author":"Pu","year":"2025","journal-title":"Discov Onc"},{"key":"10.1016\/j.slasd.2026.100331_bib0148","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/j.wneu.2022.12.052","article-title":"Effect of extent of resection on survival of patients with glioblastoma, IDH-wild-type, WHO grade 4 (WHO 2021): systematic review and meta-analysis","volume":"171","author":"Jusue-Torres","year":"2023","journal-title":"World Neurosurg"},{"key":"10.1016\/j.slasd.2026.100331_bib0149","article-title":"Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis","volume":"2","author":"Alnahhas","year":"2020","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.slasd.2026.100331_bib0150","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0151","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s40478-023-01622-w","article-title":"MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value","volume":"11","author":"Leske","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.slasd.2026.100331_bib0152","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40478-025-02046-4","article-title":"Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights","volume":"13","author":"Li","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.slasd.2026.100331_bib0153","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1166207","article-title":"An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?","volume":"13","author":"Teraiya","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0154","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/ijms25063217","article-title":"A review of approaches to potentiate the activity of temozolomide against glioblastoma to overcome resistance","volume":"25","author":"Karve","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.slasd.2026.100331_bib0155","first-page":"673","article-title":"Overcoming resistance to temozolomide in glioblastoma: a scoping review of preclinical and clinical data","volume":"14","author":"Smerdi","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.slasd.2026.100331_bib0156","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102029","article-title":"How did lomustine become standard of care in recurrent glioblastoma?","volume":"87","author":"Weller","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.slasd.2026.100331_bib0157","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.884158","article-title":"Carmustine wafers implantation in patients with newly diagnosed high grade glioma: is it still an option?","volume":"13","author":"Ricciardi","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.slasd.2026.100331_bib0158","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1200\/JCO.21.02543","article-title":"Joint final report of EORTC 26951 and RTOG 9402: phase III trials with procarbazine, Lomustine, and Vincristine chemotherapy for anaplastic oligodendroglial tumors","volume":"40","author":"Lassman","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0159","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.827897","article-title":"Initial PCV chemotherapy followed by radiotherapy is associated with a prolonged response but late neurotoxicity in 20 diffuse low-grade glioma patients","volume":"12","author":"Blonski","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0160","article-title":"Vincristine-induced peripheral neuropathy in children with malignancy and the effect of missed doses on treatment success","volume":"15","author":"Eker","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.slasd.2026.100331_bib0161","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","article-title":"Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review","volume":"84","author":"Madsen","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.slasd.2026.100331_bib0162","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/cns.15.8","article-title":"Use of bevacizumab in recurrent glioblastoma","volume":"4","author":"Ghiaseddin","year":"2015","journal-title":"CNS Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0163","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.3390\/cancers15174279","article-title":"Recurrent glioblastoma: a review of the treatment options","volume":"15","author":"Vaz-Salgado","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.slasd.2026.100331_bib0164","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.bjc.6602105","article-title":"Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma","volume":"91","author":"Franceschi","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1017\/cjn.2023.276","article-title":"The value of etoposide for recurrent glioma","volume":"51","author":"van der Meulen","year":"2024","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.slasd.2026.100331_bib0166","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1200\/OP-24-00877","article-title":"Safe outpatient treatment of CNS lymphoma achieved by using glucarpidase after high-dose methotrexate","volume":"21","author":"Cohen","year":"2025","journal-title":"JCO Oncol Pr"},{"key":"10.1016\/j.slasd.2026.100331_bib0167","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0168","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40262-024-01452-6","article-title":"Population pharmacokinetic and toxicity analysis of high-dose methotrexate in patients with Central nervous system lymphoma","volume":"64","author":"Yin","year":"2025","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.slasd.2026.100331_bib0169","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1038\/s41598-019-42001-7","article-title":"The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model","volume":"9","author":"Enr\u00edquez P\u00e9rez","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2026.100331_bib0170","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.2147\/IJN.S444319","article-title":"Advances in brain tumor therapy based on the magnetic nanoparticles","volume":"Volume 18","author":"Xu","year":"2023","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.slasd.2026.100331_bib0171","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100213","article-title":"Green chemistry: modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer","volume":"31","author":"Khafaga","year":"2025","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2026.100331_bib0172","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/pharmaceutics17070899","article-title":"Overview of preclinical and clinical trials of nanoparticles for the treatment of brain metastases","volume":"17","author":"Izhar","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.slasd.2026.100331_bib0173","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.707319","article-title":"Stimuli-responsive polymeric nanoplatforms for cancer therapy","volume":"9","author":"Chang","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.slasd.2026.100331_bib0174","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12951-022-01364-2","article-title":"Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms","volume":"20","author":"Kaushik","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.slasd.2026.100331_bib0175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/02841860500486630","article-title":"Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab","volume":"45","author":"Yau","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.slasd.2026.100331_bib0176","doi-asserted-by":"crossref","first-page":"41471","DOI":"10.1039\/D0RA07161G","article-title":"A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles","volume":"10","author":"Qiao","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.slasd.2026.100331_bib0177","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1039\/D2BM02152H","article-title":"Transferrin receptor 1 targeted nanomedicine for brain tumor therapy","volume":"11","author":"Li","year":"2023","journal-title":"Biomater Sci"},{"key":"10.1016\/j.slasd.2026.100331_bib0178","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103961","article-title":"A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy","volume":"185","author":"Bhattacharya","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.slasd.2026.100331_bib0179","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7150\/ntno.95791","article-title":"Targeted Nanotheranostics: integration of preclinical MRI and ct in the molecular imaging and therapy of advanced diseases","volume":"8","author":"Bonlawar","year":"2024","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.slasd.2026.100331_bib0180","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3390\/cancers15112906","article-title":"Metastatic breast cancer: review of emerging nanotherapeutics","volume":"15","author":"Dissanayake","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.slasd.2026.100331_bib0181","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/s41598-022-06677-8","article-title":"Dual targeting micelles loaded with paclitaxel and lapatinib for combinational therapy of brain metastases from breast cancer","volume":"12","author":"Lu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2026.100331_bib0182","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","article-title":"Regulatory aspects on nanomedicines","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.slasd.2026.100331_bib0183","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front Chem"},{"key":"10.1016\/j.slasd.2026.100331_bib0184","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.slasd.2026.100331_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120645","article-title":"An update on actively targeted liposomes in advanced drug delivery to glioma","volume":"602","author":"Mojarad-Jabali","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.slasd.2026.100331_bib0186","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/ph16081056","article-title":"Liposomes for the treatment of brain cancer\u2014a review","volume":"16","author":"Raju","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.slasd.2026.100331_bib0187","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.3390\/polym13234114","article-title":"Development of polymer-based nanoformulations for glioblastoma brain cancer therapy and diagnosis: an update","volume":"13","author":"Rabha","year":"2021","journal-title":"Polym (Basel)"},{"key":"10.1016\/j.slasd.2026.100331_bib0188","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114326","article-title":"Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy","volume":"200","author":"Ramalho","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.slasd.2026.100331_bib0189","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: a current overview of in vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.slasd.2026.100331_bib0190","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/pharmaceutics14030572","article-title":"Pharmacokinetics and pharmacodynamics of intranasal solid lipid nanoparticles and nanostructured lipid carriers for nose-to-brain delivery","volume":"14","author":"Nguyen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.slasd.2026.100331_bib0191","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3390\/molecules22091401","article-title":"Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy","volume":"22","author":"Palmerston Mendes","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.slasd.2026.100331_bib0192","doi-asserted-by":"crossref","first-page":"46290","DOI":"10.1021\/acsami.2c13129","article-title":"Dendrimer\u2013siRNA conjugates for targeted intracellular delivery in glioblastoma animal models","volume":"14","author":"Liyanage","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.slasd.2026.100331_bib0193","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/IJN.S238206","article-title":"Aptamer-conjugated gold nanoparticles targeting epidermal growth factor receptor variant III for the treatment of glioblastoma","volume":"Volume 15","author":"Peng","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.slasd.2026.100331_bib0194","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42738","article-title":"Utilizing gold nanoparticles in plasmonic photothermal therapy for cancer treatment","volume":"11","author":"Badir","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.slasd.2026.100331_bib0195","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s40001-025-02696-z","article-title":"Promising biomedical applications using superparamagnetic nanoparticles","volume":"30","author":"Fahim","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0196","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.2147\/IJN.S444319","article-title":"Advances in brain tumor therapy based on the magnetic nanoparticles","volume":"Volume 18","author":"Xu","year":"2023","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.slasd.2026.100331_bib0197","doi-asserted-by":"crossref","first-page":"49009","DOI":"10.1039\/D5RA07176C","article-title":"Recent advancements in multifunctional nanomaterials for dental applications","volume":"15","author":"El-Morsy","year":"2025","journal-title":"RSC Adv"},{"key":"10.1016\/j.slasd.2026.100331_bib0198","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.3390\/polym13234114","article-title":"Development of polymer-based nanoformulations for glioblastoma brain cancer therapy and diagnosis: an update","volume":"13","author":"Rabha","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.slasd.2026.100331_bib0199","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/0122117385271393231117063750","article-title":"Solid lipid nanoparticles as an innovative lipidic drug delivery system","volume":"13","author":"Waghmare","year":"2025","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.slasd.2026.100331_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37217","article-title":"Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: a step toward developing innovative anti-cancer therapeutics","volume":"10","author":"Muteeb","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.slasd.2026.100331_bib0201","doi-asserted-by":"crossref","unstructured":"Payamifar S, Khalili Y, Foroozandeh A, et al. Magnetic mesoporous silica nanoparticles as advanced polymeric scaffolds for efficient cancer chemotherapy: recent progress and challenges. RSC Adv 15: 16050\u201316074.","DOI":"10.1039\/D5RA00948K"},{"key":"10.1016\/j.slasd.2026.100331_bib0202","doi-asserted-by":"crossref","unstructured":"Payamifar S, Khalili Y, Foroozandeh A, et al. Magnetic mesoporous silica nanoparticles as advanced polymeric scaffolds for efficient cancer chemotherapy: recent progress and challenges. RSC Adv 15: 16050\u201316074.","DOI":"10.1039\/D5RA00948K"},{"key":"10.1016\/j.slasd.2026.100331_bib0203","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","article-title":"Nanoparticles: properties, applications and toxicities","volume":"12","author":"Khan","year":"2019","journal-title":"Arab J Chem"},{"key":"10.1016\/j.slasd.2026.100331_bib0204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jare.2015.02.007","article-title":"A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: a green expertise","volume":"7","author":"Ahmed","year":"2016","journal-title":"J Adv Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0205","first-page":"1","article-title":"Green synthesis of silver nanoparticles using Azadirachta indica aqueous leaf extract","volume":"9","author":"Ahmed","year":"2016","journal-title":"J Radiat Res Appl Sci"},{"key":"10.1016\/j.slasd.2026.100331_bib0206","article-title":"Effective approaches in conquering chemoresistance of glioblastoma: potential for nanoformulations","author":"Mandal","year":"2025","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0207","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1007\/s10570-024-05914-9","article-title":"Green synthesis of zinc oxide nanoparticles using aloe vera leaf extract and evaluation of the antimicrobial and antioxidant properties of the ZnO\/regenerated cellulose film","volume":"31","author":"Wu","year":"2024","journal-title":"Cellulose"},{"key":"10.1016\/j.slasd.2026.100331_bib0208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10238-025-01631-0","article-title":"Emerging therapeutic strategies in glioblastsoma: drug repurposing, mechanisms of resistance, precision medicine, and technological innovations","volume":"25","author":"Anwer","year":"2025","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.slasd.2026.100331_bib0209","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.colsurfa.2009.02.008","article-title":"Green synthesis of silver nanoparticles using latex of Jatropha curcas","volume":"339","author":"Bar","year":"2009","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"10.1016\/j.slasd.2026.100331_bib0210","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1007\/s10570-024-05914-9","article-title":"Green synthesis of zinc oxide nanoparticles using aloe vera leaf extract and evaluation of the antimicrobial and antioxidant properties of the ZnO\/regenerated cellulose film","volume":"31","author":"Wu","year":"2024","journal-title":"Cellulose"},{"key":"10.1016\/j.slasd.2026.100331_bib0211","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1053\/j.gastro.2023.02.025","article-title":"Targeting UBE2T potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress","volume":"164","author":"Jiang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.slasd.2026.100331_bib0212","series-title":"Green synthesis, characterization and applications of nanoparticles","first-page":"303","article-title":"Chapter 12 - nanoparticle characterization techniques","author":"Titus","year":"2019"},{"key":"10.1016\/j.slasd.2026.100331_bib0213","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12951-021-00834-3","article-title":"Green synthesis of metal nanoparticles using microorganisms and their application in the agrifood sector","volume":"19","author":"Bahrulolum","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.slasd.2026.100331_bib0214","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116316","article-title":"Green and sustainable synthesis of nanomaterials: recent advancements and limitations","volume":"231","author":"Gupta","year":"2023","journal-title":"Env Res"},{"key":"10.1016\/j.slasd.2026.100331_bib0215","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3390\/nano15231767","article-title":"From nature to nanomedicine: green-synthesized metal oxide nanoparticles for oral cancer drug delivery","volume":"15","author":"Khafaga","year":"2025","journal-title":"Nanomaterials"},{"key":"10.1016\/j.slasd.2026.100331_bib0216","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/molecules28010463","article-title":"Plant and microbial approaches as green methods for the synthesis of nanomaterials: synthesis, applications, and future perspectives","volume":"28","author":"Alsaiari","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.slasd.2026.100331_bib0217","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/catal12050459","article-title":"A review on green synthesis of nanoparticles and their diverse biomedical and environmental applications","volume":"12","author":"Samuel","year":"2022","journal-title":"Catalysts"},{"key":"10.1016\/j.slasd.2026.100331_bib0218","doi-asserted-by":"crossref","DOI":"10.1016\/j.eti.2022.102336","article-title":"Green synthesis of nanoparticles: current developments and limitations","volume":"26","author":"Ying","year":"2022","journal-title":"Environ Technol Innov"},{"key":"10.1016\/j.slasd.2026.100331_bib0219","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10311-023-01682-3","article-title":"Synthesis of green nanoparticles for energy, biomedical, environmental, agricultural, and food applications: a review","volume":"22","author":"Osman","year":"2024","journal-title":"Env Chem Lett"},{"key":"10.1016\/j.slasd.2026.100331_bib0220","first-page":"18","article-title":"Economic evaluation of zinc oxide nanoparticle production through green synthesis method using Cassia fistula plant extract","volume":"5","author":"Zahra","year":"2020","journal-title":"Int J Energ"},{"key":"10.1016\/j.slasd.2026.100331_bib0221","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1039\/C8NR02278J","article-title":"Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties","volume":"10","author":"Mourdikoudis","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.slasd.2026.100331_bib0222","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2147\/IJN.S21657","article-title":"Size-dependent in vivo toxicity of PEG-coated gold nanoparticles","volume":"6","author":"Zhang","year":"2011","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.slasd.2026.100331_bib0223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2010.02.001","article-title":"Biological synthesis of metal nanoparticles by microbes","volume":"156","author":"Narayanan","year":"2010","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.slasd.2026.100331_bib0224","doi-asserted-by":"crossref","unstructured":"Singh S., Jain B. (2024) Green synthesis of Zinc oxide nanoparticles using aloe vera: a study on optical properties and photocatalytic activity.","DOI":"10.26434\/chemrxiv-2024-83hjj"},{"key":"10.1016\/j.slasd.2026.100331_bib0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.toxrep.2023.11.008","article-title":"Silver nanoparticles induces apoptosis of cancer stem cells in head and neck cancer","volume":"12","author":"Kaur","year":"2024","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.slasd.2026.100331_bib0226","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.2147\/IJN.S523008","article-title":"A systematic review of nanoparticle-mediated ferroptosis in glioma therapy","volume":"Volume 20","author":"Jing","year":"2025","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.slasd.2026.100331_bib0227","series-title":"Green synthesis, characterization and applications of nanoparticles","first-page":"303","article-title":"Chapter 12 - nanoparticle characterization techniques","author":"Titus","year":"2019"},{"key":"10.1016\/j.slasd.2026.100331_bib0228","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.slasd.2026.100331_bib0229","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15648-y","article-title":"Green synthesis of novel stable biogenic gold nanoparticles for breast cancer therapeutics via the induction of extrinsic and intrinsic pathways","volume":"12","author":"El-Deeb","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2026.100331_bib0230","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.18632\/oncotarget.13503","article-title":"Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.slasd.2026.100331_bib0231","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2023.103312","article-title":"Gold nanoparticles-based photothermal therapy for breast cancer","volume":"42","author":"Dheyab","year":"2023","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.slasd.2026.100331_bib0232","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2024.1490980","article-title":"Plant-mediated gold nanoparticles in cancer therapy: exploring anti-cancer mechanisms, drug delivery applications, and future prospects","volume":"6","author":"Nisha","year":"2024","journal-title":"Front Nanotechnol"},{"key":"10.1016\/j.slasd.2026.100331_bib0233","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11671-025-04186-x","article-title":"Revolutionizing radiotherapy: gold nanoparticles with polyphenol coating as novel enhancers in breast cancer cells-an in vitro study","volume":"20","author":"Tarantino","year":"2025","journal-title":"Discov Nano"},{"key":"10.1016\/j.slasd.2026.100331_bib0234","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00449-023-02886-1","article-title":"Recent advances in the synthesis, characterization and biomedical applications of zinc oxide nanoparticles","volume":"46","author":"Asif","year":"2023","journal-title":"Bioprocess Biosyst Eng"},{"key":"10.1016\/j.slasd.2026.100331_bib0235","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/cryst11040344","article-title":"Green synthesis and biomedical applications of ZnO nanoparticles: role of PEGylated-ZnO nanoparticles as doxorubicin drug carrier against MDA-MB-231(TNBC) cells line","volume":"11","author":"Batool","year":"2021","journal-title":"Crystals"},{"key":"10.1016\/j.slasd.2026.100331_bib0236","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.biomaterials.2007.08.050","article-title":"Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors","volume":"29","author":"Chertok","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.slasd.2026.100331_bib0237","doi-asserted-by":"crossref","first-page":"11587","DOI":"10.1039\/D5RA00728C","article-title":"Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: a review","volume":"15","author":"Ghazi","year":"2025","journal-title":"RSC Adv"},{"key":"10.1016\/j.slasd.2026.100331_bib0238","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1049\/iet-nbt.2015.0058","article-title":"Biogenic synthesis, optimisation and antibacterial efficacy of extracellular silver nanoparticles using novel fungal isolate Aspergillus fumigatus MA","volume":"10","author":"Sarsar","year":"2016","journal-title":"IET Nanobiotechnol"},{"key":"10.1016\/j.slasd.2026.100331_bib0239","doi-asserted-by":"crossref","unstructured":"Vanlalveni C, Lallianrawna S, Biswas A, et al. Green synthesis of silver nanoparticles using plant extracts and their antimicrobial activities: a review of recent literature. RSC Adv 11: 2804\u20132837.","DOI":"10.1039\/D0RA09941D"},{"key":"10.1016\/j.slasd.2026.100331_bib0240","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.biotechadv.2013.01.003","article-title":"Synthesis of metallic nanoparticles using plant extracts","volume":"31","author":"Mittal","year":"2013","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.slasd.2026.100331_bib0241","first-page":"1","article-title":"Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)","author":"Singh","year":"2010","journal-title":"Nano Rev"},{"key":"10.1016\/j.slasd.2026.100331_bib0242","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cis.2008.09.002","article-title":"Silver nanoparticles: green synthesis and their antimicrobial activities","volume":"145","author":"Sharma","year":"2009","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.slasd.2026.100331_bib0243","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1039\/c1gc15386b","article-title":"Green synthesis of metal nanoparticles using plants","volume":"13","author":"Iravani","year":"2011","journal-title":"Green Chem"},{"key":"10.1016\/j.slasd.2026.100331_bib0244","doi-asserted-by":"crossref","first-page":"13940","DOI":"10.1021\/ja029267j","article-title":"Completely \u201cgreen\u201d synthesis and stabilization of metal nanoparticles","volume":"125","author":"Raveendran","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.slasd.2026.100331_bib0245","doi-asserted-by":"crossref","first-page":"A18","DOI":"10.1016\/j.matpr.2021.03.729","article-title":"Green synthesis of ZnO nanoparticles in grape extract: their application as anti-cancer and anti-bacterial","volume":"42","author":"Hussein","year":"2021","journal-title":"Mater Today Proc"},{"key":"10.1016\/j.slasd.2026.100331_bib0246","article-title":"Process optimization for green synthesis of gold nanoparticles mediated by extract of hygrophila spinosa T. Anders and their biological applications","volume":"121","author":"Satpathy","year":"2020","journal-title":"Phys Low Dimens Syst Nanostructures"},{"key":"10.1016\/j.slasd.2026.100331_bib0247","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/cancers12040855","article-title":"Green chemistry synthesis of silver nanoparticles and their potential anticancer effects","volume":"12","author":"Ratan","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0248","first-page":"120","article-title":"Bio-synthesis of silver nanoparticles using Potentilla fulgens Wall. Ex Hook. And its therapeutic evaluation as anticancer and antimicrobial agent. Materials science & engineering C","volume":"53","author":"Mittal","year":"2015","journal-title":"Mater Biol Appl"},{"key":"10.1016\/j.slasd.2026.100331_bib0249","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2021.100142","article-title":"Biosynthesis and characterization of nickel oxide nanoparticles by using aqueous grape extract and evaluation of their biological applications","volume":"3","author":"Hussein","year":"2021","journal-title":"Results Chem"},{"key":"10.1016\/j.slasd.2026.100331_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/21691401.2018.1489265","article-title":"Antioxidant and anticancer activities of green synthesized silver nanoparticles using aqueous extract of tubers of Pueraria tuberosa","volume":"46","author":"Satpathy","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.slasd.2026.100331_bib0251","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/pharmaceutics17080987","article-title":"Nanomedicine: the effective role of nanomaterials in healthcare from diagnosis to therapy","volume":"17","author":"Kazi","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.slasd.2026.100331_bib0252","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ijc.34542","article-title":"Nanoparticle drug delivery to target breast cancer brain metastasis: current and future trends","volume":"153","author":"Kannan","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.slasd.2026.100331_bib0253","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","article-title":"Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition","volume":"183","author":"Priem","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.slasd.2026.100331_bib0254","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nnano.2014.154","article-title":"A carbon nanotube-polymer composite for T-cell therapy","volume":"9","author":"Fadel","year":"2014","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.slasd.2026.100331_bib0255","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ultsonch.2016.11.033","article-title":"Pulsed-wave low-dose ultrasound hyperthermia selectively enhances nanodrug delivery and improves antitumor efficacy for brain metastasis of breast cancer","volume":"36","author":"Wu","year":"2017","journal-title":"Ultrason Sonochem"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:08:00Z","timestamp":1788970080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555226000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":255,"alternative-id":["S2472555226000377"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100331","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modern therapies: Nanotechnology promises new approaches for rare breast cancer brain metastases","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100331"}}